Location
France, Europe
Cheque size
$100K - $5M
Investment Stage
Seed
Series A
Series B
Focus Areas
Health IT
Health & Hospital Services
Digital Health
BioTech
Consumer Health
Pharmaceuticals
Medical Devices
About Investor
Côme Vercken is Development & Strategic Planning Director at CFAO Group and Managing Director of Health54 (now operating as Next54), the healthcare-focused corporate venture arm of CFAO. He invests $100K to $5.0M in Seed-stage and early-stage healthcare and healthtech startups across Africa, including medical devices, biotech, pharmaceuticals, digital health, and health services. Before leading Health54/Next54, he joined CFAO in 2019 to oversee divestments, acquisitions, and strategic planning and later joined the group’s Executive Committee.
Previous investments
TIBU Health
2023
Lifestores Pharmacy
3M |2022
Lifestores Healthcare
3M |2022
Similar Investors
JG
Joaquin Gomez
United Kingdom, Europe
$50K - $1M
Pre Seed
,Seed
,WT
William Tunstall-Pedoe
United Kingdom, Europe
$10K - $500K
Pre Seed
,Seed
,CJ
Christoph Janz
Germany, Europe
$580K - $3.5M
Pre Seed
,Seed
,IT
Igor Tikhturov
United Kingdom, Europe
$100K - $5M
Pre Seed
,Seed
,EV
Eze Vidra
United Kingdom, Europe
$300K - $1.5M
Pre Seed
,Seed
,PL
Pierre-Eric Leibovici
France, Europe
$500K - $10M
Seed
,Series A
,Is this Your Profile?
If you have any updates, please fill out our form.